Relationship Between Red Cell Distribution Width (RDW) and HbA1C in Patients With Type 2 Diabetes Mellitus After Glycemic Control
New Valley University
250 participants
Dec 1, 2025
OBSERVATIONAL
Conditions
Summary
Diabetes mellitus (DM) is an epidemic disease, with approximately 463 million persons diagnosed with it. Of those, 90% are patients with type 2 DM (T2DM). Some estimates indicate that 700 million cases of DM will be reported in 2045. T2DM develops due to insulin resistance, leading to reduced insulin secretion. DM has a number of associated complications, such as nephropathy, neuropathy, and cardiovascular disease.
Eligibility
Inclusion Criteria1
- Patients diagnosed to have Uncontrolled type 2 diabetes mellitus (HbA1C more than 7%)
Exclusion Criteria6
- Patients diagnosed to have type 1 diabetes.
- Patients are diagnosed to have secondary diabetes.
- Clinical states associated with increased RDW:
- Anemia (Female Hb less than 12, Male Hb less than 13) either due to hemolysis, or in response to ineffective red cell production, which can be caused by deficiencies in iron, vitamin B12 or folate.
- After blood transfusions
- Pregnancy, thrombotic thrombocytopenic purpura and inflammatory bowel disease.
Interventions
Blood test will be done at time of recruitment (for 2 groups) , after 3 months and after 6 months (for group 1 )
Blood test will be done at time of recruitment (for 2 groups) , after 3 months and after 6 months (for group 1 )
Blood test will be done at time of recruitment (for 2 groups) , after 3 months and after 6 months (for group 1 )
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06067399